Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Interchange of vaccine products, Oesophageal food impaction, SARS-CoV-2 test
Clinical narrative: had an impaction of food in my esophagus due to eosinophilic esophagitis; Interchange of vaccine products; COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) and OESOPHAGEAL FOOD IMPACTION (had an impaction of food in my esophagus due to eosinophilic esophagitis) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    Concurrent medical conditions included Eosinophilic esophagitis.   In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Nov-2021 at 10:00 PM, the patient received dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 02-May-2022, the patient experienced OESOPHAGEAL FOOD IMPACTION (had an impaction of food in my esophagus due to eosinophilic esophagitis) (seriousness criteria hospitalization and medically significant). On an unknown date, the patient experienced COVID-19 (COVID-19) (seriousness criterion medically significant) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 21-Apr-2022 to 26-Apr-2022 for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19), OESOPHAGEAL FOOD IMPACTION (had an impaction of food in my esophagus due to eosinophilic esophagitis) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Apr-2022, SARS-CoV-2 test: negative (Negative) Negative, after testing at-home rapid.. On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  It was reported that after testing negative on an at-home rapid test on 2022-04-26, and following the isolation and masking protocols, patient had an impaction of food in esophagus due to eosinophilic esophagitis. During the hospital stay, patient tested positive on a rapid test and continue to test positive through 07-MAY-2022. Symptoms were mild, including lingering cough and some nasal congestion. It was reported that patient received full dose of Moderna followed by Pfizer booster,  Company comment: This spontaneous case concerns a 41-year-old male patient with relevant medical history of Eosinophilic esophagitis and interchange of vaccine products, who experienced the unexpected serious (hospitalization) events Oesophageal food impaction and Covid- 19 (AESI), after receiving a dose of mRNA-1273 vaccine (date unspecified) and 177 days after receiving a dose of TOZINAMERAN - PFIZER BIONTECH COVID-19 VACCINE (received as booster). The patient had an impaction of food in oesophagus due to eosinophilic esophagitis. During the hospital stay, patient tested positive for COVID19 on a rapid test with mild symptoms including lingering cough and some nasal congestion which was treated with Paxlovid (Nirmatrelvir + Ritonavir) for COVID19. The outcome was reported as unknown. Oesophageal food impaction can be secondary to medical history of eosinophilic esophagitis. Current pandemia could be the confounder for Covid 19. Patient has received Full dose of Moderna followed by Pfizer booster. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 41-year-old male patient with relevant medical history of Eosinophilic esophagitis and interchange of vaccine products, who experienced the unexpected serious (hospitalization) events Oesophageal food impaction and Covid- 19 (AESI), after receiving a dose of mRNA-1273 vaccine (date unspecified) and 177 days after receiving a dose of TOZINAMERAN - PFIZER BIONTECH COVID-19 VACCINE (received as booster). The patient had an impaction of food in oesophagus due to eosinophilic esophagitis. During the hospital stay, patient tested positive for COVID19 on a rapid test with mild symptoms including lingering cough and some nasal congestion which was treated with Paxlovid (Nirmatrelvir + Ritonavir) for COVID19. The outcome was reported as unknown. Oesophageal food impaction can be secondary to medical history of eosinophilic esophagitis. Current pandemia could be the confounder for Covid 19. Patient has received Full dose of Moderna followed by Pfizer booster. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.